UBS Group’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.16M | Buy |
|
|||||
|
2024
Q3 | $199K | Buy |
|
|||||
|
2024
Q2 | $157K | Sell |
|
|||||
|
2024
Q1 | $240K | Buy |
|
|||||
|
2023
Q4 | $225K | Buy |
|
|||||
|
2023
Q3 | $85.2K | Sell |
|
|||||
|
2023
Q2 | $69K | Buy |
|
|||||
|
2023
Q1 | $37K | Buy |
|
|||||
|
2022
Q4 | $22.1K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $67K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $20K | Sell |
|
|||||
|
2021
Q1 | $1.13M | Buy |
|
|||||
|
2020
Q4 | $1.19M | Buy |
|
|||||
|
2020
Q3 | $941K | Buy |
|